New attack on clinical research in Denmark: It is way too expensive
Even though the fees for clinical research have been lowered, it is still so expensive to conduct studies on new drugs in Denmark that it threatens future studies according to several representatives from the industry. Danish Regions believes that the industry should accept its share of the payment.
It has been said time and time again that it is too expensive to conduct clinical trials in Denmark.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
